211 related articles for article (PubMed ID: 15570291)
1. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
[TBL] [Abstract][Full Text] [Related]
2. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
[TBL] [Abstract][Full Text] [Related]
3. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
[TBL] [Abstract][Full Text] [Related]
4. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
5. Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody.
da Fonseca LM; Brunetti IL; Rego EM; Garcia AB; Cilento G; Falcão RP
Acta Haematol; 1993; 90(1):19-24. PubMed ID: 8237269
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
7. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
8. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE
Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
10. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
11. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
[TBL] [Abstract][Full Text] [Related]
12. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
13. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
14. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with minimal differentiation (AML M0) mimicking acute lymphoblastic leukemia.
Shanmugam V; Dorfman DM
Am J Hematol; 2019 Aug; 94(8):955-956. PubMed ID: 30431665
[No Abstract] [Full Text] [Related]
16. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
17. Childhood T-acute lymphoblastic leukemia relapsed as minimally differentiated acute myeloid leukemia (AML-M0).
Ortín X; Escoda L; Nomdedeu J; Llorente A; Cabezudo E; Boixadera J; Ugarriza A
Leuk Lymphoma; 2003 Dec; 44(12):2159-61. PubMed ID: 14959865
[No Abstract] [Full Text] [Related]
18. Morphology and classification of acute myeloid leukemias.
Krause JR
Clin Lab Med; 2000 Mar; 20(1):1-16. PubMed ID: 10702892
[TBL] [Abstract][Full Text] [Related]
19. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]